This company listing is no longer active
Clovis Oncology Dirección
Dirección controles de criterios 3/4
Clovis Oncology's CEO is Patrick Mahaffy, appointed in Apr 2009, he has a tenure of 14.25 years. He directly owns 0.67% of the company’s shares, worth €14.56K. The average tenure of the management team and the board of directors is 7.4 years and 14.3 years respectively.`
Información clave
Patrick Mahaffy
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | 14.3yrs |
Participación del CEO | 0.7% |
Permanencia media de la dirección | 7.4yrs |
Promedio de permanencia en la Junta Directiva | 14.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$252m |
Jun 30 2022 | n/a | n/a | -US$263m |
Mar 31 2022 | n/a | n/a | -US$258m |
Dec 31 2021 | US$3m | US$739k | -US$265m |
Sep 30 2021 | n/a | n/a | -US$299m |
Jun 30 2021 | n/a | n/a | -US$310m |
Mar 31 2021 | n/a | n/a | -US$336m |
Dec 31 2020 | US$3m | US$721k | -US$369m |
Sep 30 2020 | n/a | n/a | -US$370m |
Jun 30 2020 | n/a | n/a | -US$385m |
Mar 31 2020 | n/a | n/a | -US$413m |
Dec 31 2019 | US$7m | US$719k | -US$400m |
Sep 30 2019 | n/a | n/a | -US$400m |
Jun 30 2019 | n/a | n/a | -US$396m |
Mar 31 2019 | n/a | n/a | -US$377m |
Dec 31 2018 | US$6m | US$689k | -US$368m |
Sep 30 2018 | n/a | n/a | -US$321m |
Jun 30 2018 | n/a | n/a | -US$291m |
Mar 31 2018 | n/a | n/a | -US$366m |
Dec 31 2017 | US$9m | US$636k | -US$346m |
Sep 30 2017 | n/a | n/a | -US$365m |
Jun 30 2017 | n/a | n/a | -US$370m |
Mar 31 2017 | n/a | n/a | -US$324m |
Dec 31 2016 | US$789k | US$224k | -US$349m |
Compensación vs. Mercado: Insufficient data to establish whether Patrick's total compensation is reasonable compared to companies of similar size in the German market.
Compensación vs. Ingresos: Patrick's compensation has been consistent with company performance over the past year.
CEO
Patrick Mahaffy (60 yo)
14.3yrs
Permanencia
US$2,639,083
Compensación
Mr. Patrick J. Mahaffy, M.A., co-founded Clovis Oncology, Inc. in April 20, 2009 and has been its Chief Executive Officer and President since April 20, 2009. Mr. Mahaffy served as the Chief Executive Offic...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Co-Founder | 14.3yrs | US$2.64m | 0.67% $ 14.6k | |
Executive VP & CFO | 7.3yrs | US$1.19m | 0.072% $ 1.6k | |
Executive VP | 7.5yrs | US$1.20m | 0.068% $ 1.5k | |
Executive VP of Clinical Development & Pharmacovigilance and Chief Medical Officer | 7.9yrs | US$1.24m | 0.078% $ 1.7k | |
Executive VP & Chief Scientific Officer | 3.8yrs | sin datos | sin datos | |
Executive Vice President of Human Resources | 6.8yrs | sin datos | sin datos |
7.4yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: C6O's management team is seasoned and experienced (7.4 years average tenure).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
Co-Founder | 14.3yrs | US$2.64m | 0.67% $ 14.6k | |
Independent Director | 14.3yrs | US$260.00k | 0.041% $ 889.9 | |
Independent Director | 14.5yrs | US$270.00k | 0.040% $ 875.1 | |
Independent Director | 14.5yrs | US$270.00k | 0.17% $ 3.8k | |
Independent Director | 14.5yrs | US$270.00k | 0.044% $ 953.2 | |
Independent Chairman | 10.5yrs | US$287.50k | 0% $ 0 | |
Independent Director | 14.5yrs | US$257.50k | 0.040% $ 872.7 | |
Director | 2yrs | US$375.21k | sin datos | |
Independent Director | 10.5yrs | US$259.58k | 0% $ 0 | |
Independent Director | 4.8yrs | US$257.50k | 0% $ 0 | |
Independent Director | 4.8yrs | US$255.00k | 0% $ 0 |
14.3yrs
Permanencia media
67yo
Promedio de edad
Junta con experiencia: C6O's board of directors are seasoned and experienced ( 14.3 years average tenure).